Stock Rich List
NYSE: LCTX

Lineage Cell Therapeutics insiders

The officers, directors and 10% owners of Lineage Cell Therapeutics, Inc. who hold the most stock, valued at the live LCTX price.

$0.82
LCTX today −$19K (−2.21%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
3
Their LCTX stock
$128M
Market value
$207M
Held by ranked insiders
61.7%

Insiders by value of LCTX holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Broadwood Capital INC10% owner99,121,984$81.3M39.2%Corporate
2Broadwood Partners, L.P.Director50,560,992$41.5M20.0%Corporate
3Alfred D. KingsleyDirector6,473,891$5.3M2.56%13802nd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Lineage Cell Therapeutics; see each profile for the filing.